United States

People: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

11:07am EDT
Change (% chg)

$-0.01 (-0.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kapoor, John 

Dr. John N. Kapoor, Ph.D. serves as Chairman of the Board of Akorn, Inc., Dr. Kapoor served as our interim Chief Executive Officer from March 2001 to May 2002 and as our Chief Executive Officer from May 2002 to December 2002. Dr. Kapoor is the President of EJ Financial Enterprises, Inc., a healthcare consulting and investment company. Dr. Kapoor is a director (and former chairman, President and Chief Executive Officer) of Insys Therapeutics, Inc. (NASDAQ: INSY), a publicly held drug development company focused on pain and oncology, into which NeoPharm, Inc. (previously a publicly held biopharmaceutical company) merged in October 2010. Prior to NeoPharm’s merger, Dr. Kapoor was the chairman of its board of directors. Previously, Dr. Kapoor was the chairman of the board of directors of Option Care, Inc., a leading provider of home infusion pharmacy and specialty pharmacy services, which was acquired by Walgreen Co. in August 2007. Dr. Kapoor received his Ph.D. in Medicinal Chemistry from the State University of New York at Buffalo and a B.S. in Pharmacy from Bombay University in India. Under agreements between Akorn and the John N. Kapoor Trust dated 9/20/89 (the “Kapoor Trust”), the beneficiary and sole trustee of which is Dr. John N. Kapoor, the Kapoor Trust is entitled to designate one individual to be nominated and recommended by our Board for election as a director. Dr. Kapoor was designated by the Kapoor Trust for this purpose.

Basic Compensation

Total Annual Compensation, USD 125,000
Restricted Stock Awards, USD 137,500
Long-Term Incentive Plans, USD --
All Other, USD 137,500
Fiscal Year Total, USD 400,000

Options Compensation

  Quantity Market Value
Exercisable 385,000 --
Unexercisable 125,000 --
Exercised 5,000 20,475.00
Name Fiscal Year Total

John Kapoor


Rajat Rai


Duane Portwood


Bruce Kutinsky


Joseph Bonaccorsi


Jonathon Kafer

As Of  30 Dec 2016